Optional techniques for assaying linear sodium polyphosphatesLATHAN, B. R.American laboratory (Fairfield). 1999, Vol 31, Num 4, pp 36-46, issn 0044-7749, 6 p.Article

Cloning of human tumor cell lines in porous glass capillary tubes : a further development of the human tumor stem cell assayWEISSER, H; SCHNABEL, R; LANGER, P et al.International journal of cell cloning. 1992, Vol 10, Num 6, pp 352-358, issn 0737-1454Article

INTRATUMORALE CHEMOTHERAPIE MIT BLEOMYCIN-EMULSION = CHIMIOTHERAPIE INTRATUMORALE PAR EMULSION DE BLEOMYCINEBIER J; BIER H; LATHAN B et al.1981; DTSCH. Z. MUND-KIEFER-GESICHTS.-CHIR.; ISSN 0343-3137; DEU; DA. 1981; VOL. 5; NO 6; PP. 335-340; ABS. ENG; BIBL. 5 REF.Article

Selective growth-inhibition of multidrug-resistant CHO-cells by the monoclonal antibody 265/F4EFFERTH, T; LATHAN, B; VOLM, M et al.British journal of cancer. 1991, Vol 64, Num 1, pp 87-89, issn 0007-0920, 3 p.Article

Use of a human tumor cloning system to evaluate analogs of methotrexate and mitoxantrone = Utilisation d'un système de clonage des tumeurs humaines pour évaluer des analogues du méthotrexate et de la mitoxantroneLATHAN, B; VON HOFF, D. D; ELSLAGER, E et al.Cancer treatment reports. 1984, Vol 68, Num 5, pp 733-738, issn 0361-5960Article

Pretherapeutic drug testing in acute leukemias for prediction of individual prognosisLATHAN, B; VON TETTAU, M; VERPOORT, K et al.Haematology and blood transfusion. 1990, Vol 33, pp 295-298, issn 0171-7111Article

Immunohistochemical detection of P-glycoprotein in normal and malignant tissues: a comparative study of three monoclonal antibodies, JSB-1, C 219 and 265/F4, against different epitopes using frozen and paraffin tissue sectionsBITTL, A; NAP, M; JÄGER, W et al.Tumor biology. 1993, Vol 14, Num 3, pp 155-166, issn 1010-4283Article

Cytotoxic activity of 9-β-D-arabinofuranosyl-2-fluoroadenine 5-monophosphate (fludarabine, NSC 312887) in a human tumor cloning systemLATHAN, B; DIEHL, V; CLARK, G. M et al.European journal of cancer & clinical oncology. 1988, Vol 24, Num 12, pp 1891-1895, issn 0277-5379Article

Binding of monoclonal anti-interleukin 2 antibody to nucleoli in acute leukemia blast cellsSCHWONZEN, M; PFREUDSCHUH, M; POHL, C et al.Leukemia research. 1992, Vol 16, Num 6/7, pp 589-595, issn 0145-2126Article

The clinical relevance of IgG subclasses in acute leukemias : low serum IgG as a risk factor for early death due to infection in acute myelogenous leukemiaGAUSE, A; SCHMITZ, G; VON KALLE, A.-K et al.Leukemia research. 1992, Vol 16, Num 2, pp 165-171, issn 0145-2126Article

Improved plating efficiencies for human tumors cloned in capillary tubes bersus petri dishesVON HOFF, D. D; FORSETH, B. J; HUONG, M et al.Cancer research (Baltimore). 1986, Vol 46, Num 8, pp 4012-4017, issn 0008-5472Article

Evaluation of an amsacrine analog in a human tumor cloning systemLATHAN, B; VON HOFF, D. D; CLARK, G. M et al.Cancer chemotherapy and pharmacology. 1989, Vol 24, Num 4, pp 230-232, issn 0344-5704Article

Ruminal nitrogen disappearance from sod-seeded cereal grain forages in Northern ArkansasCOBLENTZ, Wayne K; COFFEY, Kenneth P; HUBBELL, Donald S et al.Animal feed science and technology. 2001, Vol 89, Num 1-2, pp 17-32, issn 0377-8401Article

Dose escalation of cytotoxic drugs using haematopoietic growth factors : A randomized trial to determine the magnitude of increase provided by GM-CSFPFREUNDSCHUH, M; HASENCLEVER, D; FRANKLIN, J et al.Annals of oncology. 2001, Vol 12, Num 4, pp 471-477, issn 0923-7534Article

Combined effect of very early intensification and prolonged post-remission chemotherapy in patients with AMLBÜCHNER, T; HIDDEMANN, W; SCHAEFER, U. W et al.Leukemia. 1992, Vol 6, pp 68-70, issn 0887-6924, SUP4Conference Paper

Male gonadal dysfunction in patients with Hodgkin's disease prior to treatmentRUEFFER, U; BREUER, K; NISTERS-BACKES, H et al.Annals of oncology. 2001, Vol 12, Num 9, pp 1307-1311, issn 0923-7534Article

Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens : a trial of the German Hodgkin's disease study groupPFREUNDSCHUH, M. G; RUEFFER, U; LOEFFLER, M et al.Journal of clinical oncology. 1994, Vol 12, Num 3, pp 580-586, issn 0732-183XArticle

Proposal for the classification of relapsed and refractory acute myeloid leukemias as the basis for an age-adjusted randomized comparison of sequentially applied high-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone (S-HAM)HIDDEMANN, W; AUL, H. C; BETTELHEIM, P et al.Haematology and blood transfusion. 1990, Vol 33, pp 604-609, issn 0171-7111Article

Effect of treatment with rhGM-CSF and low-dose cytosine arabinoside on leukemic blast cells in patients with myelodysplastic syndromesHOELZER, D; GANSER, A; VERHAEF, G et al.Haematology and blood transfusion. 1990, Vol 33, pp 763-769, issn 0171-7111Article

Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy : A study of the German Hodgkin's lymphoma study groupTESCH, H; DIEHL, V; SCHWIEDER, G et al.Blood. 1998, Vol 92, Num 12, pp 4560-4567, issn 0006-4971Article